Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow Print PDF (610K) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (21)
Right arrowRequest Permissions
Right arrow Commercial Re-use Guidelines
for Open Access NAR Content
Google Scholar
Right arrow Articles by Scohy, S.
Right arrow Articles by Szpirer, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Scohy, S.
Right arrow Articles by Szpirer, J.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Nucleic Acids Research, 2000, Vol. 28, No. 19 3743-3751
© 2000 Oxford University Press

Identification of an enhancer and an alternative promoter in the first intron of the {alpha}-fetoprotein gene

Sophie Scohy, Philippe Gabant, Claude Szpirer and Josiane Szpirer*

Université Libre de Bruxelles, IBMM, 12 Rue Pr. Jeener and Brachet, B-6041 Gosselies, Belgium

In this study we have characterized a positive regulatory region located in the first intron of the {alpha}-fetoprotein (AFP) gene. We show that the enhancer activity of the region depends on a 44 bp sequence centered on a CACCC motif. The sequence is the target of the two zinc fingers transcription factors BKLF and YY1. The introduction of a mutation destroying the CACCC box impairs the binding of BKLF but improves that of YY1. Moreover, the mutated sequence behaves as a negative control element, suggesting that BKLF behaves as a positive factor and that YY1 is a negative one. We also demonstrate the existence of a novel, tissue-specific AFP mRNA isoform present in the yolk sac and fetal liver which initiates from an alternative promoter located ~100 bp downstream of the enhancer element. The transcriptional start site controlled by this new promoter (called P2), was mapped to 66 bp downstream of a TATA box. A putative AUG translation site in-frame with exon 2 of the classical gene was found 295 bp downstream of the transcription start site. Like the traditional AFP promoter (P1), the P2 promoter is active in the yolk sac and fetal liver. Embryonic stem cells with an AFP knock-in gene containing either the P2 promoter or deleted for it were isolated and comparative analysis of embryonic bodies derived from these cells suggests that the P2 promoter contributes to early expression of the AFP gene.

* To whom correspondence should be addressed. Tel: +32 2 650 97 06; Fax: +32 2 650 97 00; Email: jszpirer@dbm.ulb.ac.be


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
EndocrinologyHome page
M.-L. Baudet, B. Martin, Z. Hassanali, E. Parker, E. J. Sanders, and S. Harvey
Expression, Translation, and Localization of a Novel, Small Growth Hormone Variant
Endocrinology, January 1, 2007; 148(1): 103 - 115.
[Abstract] [Full Text] [PDF]


Home page
Plant Physiol.Home page
A. B. Sivitz, A. Reinders, M. E. Johnson, A. D. Krentz, C. P.L. Grof, J. M. Perroux, and J. M. Ward
Arabidopsis Sucrose Transporter AtSUC9. High-Affinity Transport Activity, Intragenic Control of Expression, and Early Flowering Mutant Phenotype
Plant Physiology, January 1, 2007; 143(1): 188 - 198.
[Abstract] [Full Text] [PDF]


Home page
Reproductive SciencesHome page
H. Fukasaw, H. Iwamoto, S. Hirata, T. Shoda, S. Yokota, S. Nishi, and K. Hoshi
Novel Human Alpha-Fetoprotein mRNA Isoform Lacking Exon 1 Identified in Ovarian Yolk Sac Tumor
Reproductive Sciences, September 1, 2005; 12(6): 456 - 462.
[Abstract] [PDF]


Home page
Hum ReprodHome page
T. Yahata, J. Quan, N. Tamura, H. Nagata, T. Kurabayashi, and K. Tanaka
Association between single nucleotide polymorphisms of estrogen receptor {alpha} gene and efficacy of HRT on bone mineral density in post-menopausal Japanese women
Hum. Reprod., July 1, 2005; 20(7): 1860 - 1866.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
A. Dupont, P. Fontana, C. Bachelot-Loza, J.-L. Reny, I. Bieche, F. Desvard, M. Aiach, and P. Gaussem
An intronic polymorphism in the PAR-1 gene is associated with platelet receptor density and the response to SFLLRN
Blood, March 1, 2003; 101(5): 1833 - 1840.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. K. Swamynathan and J. Piatigorsky
Orientation-dependent Influence of an Intergenic Enhancer on the Promoter Activity of the Divergently Transcribed Mouse Shsp/alpha B-crystallin and Mkbp/HspB2 Genes
J. Biol. Chem., December 13, 2002; 277(51): 49700 - 49706.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
P. Gabant, L. Forrester, J. Nichols, T. Van Reeth, C. De Mees, B. Pajack, A. Watt, J. Smitz, H. Alexandre, C. Szpirer, et al.
Alpha-fetoprotein, the major fetal serum protein, is not essential for embryonic development but is required for female fertility
PNAS, October 1, 2002; 99(20): 12865 - 12870.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H. Kubota, R. W. Storms, and L. M. Reid
Variant Forms of alpha -Fetoprotein Transcripts Expressed in Human Hematopoietic Progenitors. IMPLICATIONS FOR THEIR DEVELOPMENTAL POTENTIAL TOWARDS ENDODERM
J. Biol. Chem., July 26, 2002; 277(31): 27629 - 27635.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
D. M. Herrington, T. D. Howard, G. A. Hawkins, D. M. Reboussin, J. Xu, S. L. Zheng, K. B. Brosnihan, D. A. Meyers, and E. R. Bleecker
Estrogen-Receptor Polymorphisms and Effects of Estrogen Replacement on High-Density Lipoprotein Cholesterol in Women with Coronary Disease
N. Engl. J. Med., March 28, 2002; 346(13): 967 - 974.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.